Want to learn more about our services in Europe?
Contact Us

Dedicated to cell & gene therapies development and manufacturing

 

Cell and gene therapies are poised to serve a global patient population. However, companies working in this space face challenges in terms of supply chain complexity. The close proximity of manufacturing to patients is key for the success of many cell and gene therapies.

As part of our global network of manufacturing sites, our two facilities in Geleen and Maastricht in the Netherlands help you overcome this challenge. The sites provide flexible capacity and serve customers who need a European manufacturing footprint. 

Our Netherlands sites bring in significant expertise in cell and gene therapy manufacturing. As the CDMO that has supported a number of commercial autologous cell therapy products in Europe, we are committed to using our expertise to help you develop and commercialize your products quickly and efficiently, so that you can ultimately deliver therapy to patients in need of treatment.


2
manufacturing facilities in Geleen & Maastricht
55k
square feet
2005
year established

A full range of services in the heart of Europe


We offer a full range of development and manufacturing services for cell and gene therapies. Our experience covers many cell types including T-cells, dendritic cells, pluripotent stem cells and mesenchymal stem cells. We can provide tailored support at all stages, from process development to first-in-human trials and commercial production.

service
cGMP manufacturing
Leverage our established clinical and commercial manufacturing capabilities for your cell/gene therapy.
service
Allogeneic cell therapy
Flexible and scalable manufacturing services that can help bring your allogeneic therapies from concept to patient. Learn more about Lonza's offering.
service
Process development
Best-in-class Process Development & Bioassay services to derisk your manufacturing process for cGMP clinical and commercial manufacturing
service
Autologous cell therapy
End-to-end development and manufacturing services to help you achieve commercial viability for your autologous cell and gene therapies.

European cell and gene therapy manufacturing


With world-class expertise and customizable services, our Netherlands sites can help you develop and commercialize your cell and gene therapy products.

Unique Expertise

Through our experience in manufacturing cell therapy products in Europe, we are well-placed to help you in your commercialization journey. Our expertise allows us to offer several release bioassays in-house, shortening your timelines for manufacture, testing and release.  We provide regulatory affairs consultancy and support.

Part of global network

By working with our sites in Geleen and Maastricht, you will have access to our global network of Centers of Excellence which covers three continents.

Bringing your therapy from concept to patient

Our Netherlands sites are fully dedicated to cell and gene therapy. We can support your product at all stages of its lifecycle, from process developments all the way to commercial product manufacturing.